These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Subcutaneous heparin for thrombosis in pregnant women with hereditary antithrombin deficiency. Brandt P; Stenbjerg S Lancet; 1979 Jan; 1(8107):100-1. PubMed ID: 84100 [No Abstract] [Full Text] [Related]
13. Heparin: an overview. Maguire FW Del Med J; 1979 Aug; 51(8):439-49. PubMed ID: 385374 [No Abstract] [Full Text] [Related]
14. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. Basu D; Gallus A; Hirsh J; Cade J N Engl J Med; 1972 Aug; 287(7):324-7. PubMed ID: 5041701 [No Abstract] [Full Text] [Related]
15. Adjusting heparin infusion rates from the initial response to activated coagulation time. Hattersley PG; Mitsuoka JC; Ignoffo RJ; King JH; Musallam NA Drug Intell Clin Pharm; 1983 Sep; 17(9):632-4. PubMed ID: 6617481 [TBL] [Abstract][Full Text] [Related]
16. Control of heparin therapy. Wessler S; Gitel S Prog Hemost Thromb; 1976; 3():311-29. PubMed ID: 781735 [No Abstract] [Full Text] [Related]
17. [Heparin-induced hemorrhage in the treatment of venous thromboembolism]. Monreal M; Casals A; Las Heras G; Roncalés J; Callejas JM; Martorell A; Lisbona C Angiologia; 1990; 42(1):11-5. PubMed ID: 2321800 [TBL] [Abstract][Full Text] [Related]